Narcolepsy with cataplexy, The Lancet, vol.369, issue.9560, pp.499-511, 2007. ,
DOI : 10.1016/S0140-6736(07)60237-2
URL : https://hal.archives-ouvertes.fr/hal-00534816
Increase of histaminergic tuberomammillary neurons in narcolepsy, Annals of Neurology, vol.42, issue.6, pp.794-804, 2013. ,
DOI : 10.1002/ana.24019
Interactions of the histamine and hypocretin systems in CNS disorders, Nature Reviews Neurology, vol.130, issue.7, pp.401-414, 2015. ,
DOI : 10.1038/nrneurol.2015.99
Normal Cerebrospinal Fluid Histamine and tele-Methylhistamine Levels in Hypersomnia Conditions, SLEEP, vol.35, pp.1359-66, 2012. ,
DOI : 10.5665/sleep.2114
Orexin receptor 2 expression in the posterior hypothalamus rescues sleepiness in narcoleptic mice, Proceedings of the National Academy of Sciences, vol.108, issue.11, pp.4471-76, 2011. ,
DOI : 10.1073/pnas.1012456108
Pitolisant versus placebo or modafinil in patients with narcolepsy: a double-blind, randomised trial, The Lancet Neurology, vol.12, issue.11, pp.1068-75, 2013. ,
DOI : 10.1016/S1474-4422(13)70225-4
Antidepressant drugs for narcolepsy, Cochrane Database Syst Rev, vol.23, pp.3724-3733, 2008. ,
Narcolepsy and effectiveness of gamma-hydroxybutyrate (GHB): A systematic review and meta-analysis of randomized controlled trials, Sleep Medicine Reviews, vol.16, issue.5, pp.431-443, 2012. ,
DOI : 10.1016/j.smrv.2011.09.001
Cataplexy-Active Neurons in the Hypothalamus, Neuron, vol.42, issue.4, pp.619-653, 2004. ,
DOI : 10.1016/S0896-6273(04)00247-8
??-Hydroxybutyrate/Sodium Oxybate, CNS Drugs, vol.29, issue.7, pp.993-1018, 2006. ,
DOI : 10.2165/00023210-200620120-00004
EFNS guidelines on management of narcolepsy, European Journal of Neurology, vol.13, issue.1, pp.1035-1083, 2006. ,
DOI : 10.1002/ana.20339
Practice parameters for the treatment of narcolepsy and other hypersomnias of central origin, Sleep, vol.30, pp.1705-1716, 2007. ,
An inverse agonist of the histamine H3 receptor improves wakefulness in narcolepsy: Studies in orexin???/??? mice and patients, Neurobiology of Disease, vol.30, issue.1, pp.74-83, 2008. ,
DOI : 10.1016/j.nbd.2007.12.003
URL : https://hal.archives-ouvertes.fr/inserm-00215993
Amygdala Lesions Reduce Cataplexy in Orexin Knock-Out Mice, Journal of Neuroscience, vol.33, issue.23, pp.9734-9776, 2013. ,
DOI : 10.1523/JNEUROSCI.5632-12.2013
URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3704329
Role of the Medial Prefrontal Cortex in Cataplexy, Journal of Neuroscience, vol.33, issue.23, pp.9743-51, 2013. ,
DOI : 10.1523/JNEUROSCI.0499-13.2013
The Brain Correlates of Laugh and Cataplexy in Childhood Narcolepsy, Journal of Neuroscience, vol.35, issue.33, pp.11583-94, 2015. ,
DOI : 10.1523/JNEUROSCI.0840-15.2015
A detailed autoradiographic mapping of histamine H3 receptors in rat brain areas, Neuroscience, vol.52, issue.1, pp.169-89, 1993. ,
DOI : 10.1016/0306-4522(93)90191-H
The histamine H3 receptor: from discovery to clinical trials with pitolisant, British Journal of Pharmacology, vol.39, issue.4, pp.713-734, 2011. ,
DOI : 10.1111/j.1476-5381.2011.01286.x
1-{3-[3-(4-Chlorophenyl) propoxy] propyl} piperidine, hydrochloride], a non-imidazole inverse agonist/antagonist at the human histamine H3 receptor: preclinical pharmacology ,
receptor inverse agonist/antagonist compared with Modafinil, British Journal of Pharmacology, vol.329, issue.3, pp.632-676, 2013. ,
DOI : 10.1111/bph.12149
URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3682710
Pitolisant versus placebo or modafinil in patients with narcolepsy: a double-blind, randomised trial, The Lancet Neurology, vol.12, issue.11, pp.1068-75, 2013. ,
DOI : 10.1016/S1474-4422(13)70225-4
for the HARMONY-CTP study group. Safety and efficacy of pitolisant on cataplexy in patients with narcolepsy: a randomised, double-blind, placebo-controlled trial, Lancet Neurol, issue.16, pp.1474-442230333, 2017. ,
Increase of histaminergic tuberomammillary neurons in narcolepsy, Annals of Neurology, vol.42, issue.6, pp.794-804, 2013. ,
DOI : 10.1002/ana.24019
Narcolepsy and Predictors of Positive MSLTs in the Wisconsin Sleep Cohort, SLEEP, vol.37, pp.1043-51, 2014. ,
DOI : 10.5665/sleep.3758
Multiple sleep latency measures in narcolepsy and behaviourally induced insufficient sleep syndrome, Sleep Medicine, vol.10, issue.10, pp.1146-50, 2009. ,
DOI : 10.1016/j.sleep.2009.03.008
URL : http://www.zora.uzh.ch/20548/1/SLEEP-Vpdf.pdf
Test-Retest Reliability of the Multiple Sleep Latency Test in Narcolepsy without Cataplexy and Idiopathic Hypersomnia, Journal of Clinical Sleep Medicine, vol.9, pp.789-95, 2013. ,
DOI : 10.5664/jcsm.2922
Sleep stage sequence analysis of sleep onset REM periods in the hypersomnias, Journal of Neurology, Neurosurgery & Psychiatry, vol.84, issue.2, pp.223-250, 2013. ,
DOI : 10.1136/jnnp-2012-303578
Nocturnal Rapid Eye Movement Sleep Latency for Identifying Patients With Narcolepsy/Hypocretin Deficiency, JAMA Neurology, vol.70, issue.7, pp.891-902, 2013. ,
DOI : 10.1001/jamaneurol.2013.1589
Do enteric neurons make hypocretin?, Regulatory Peptides, vol.147, issue.1-3, pp.1-3, 2008. ,
DOI : 10.1016/j.regpep.2007.11.006
URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2276606